Chunghwa Chemical Synthesis & Biotech Co Ltd (1762 TW) stock market data APIs
Chunghwa Chemical Synthesis & Biotech Co Ltd Financial Data Overview
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacturing, and sale of active pharmaceutical ingredients in Taiwan, the United States, India, Greece, Croatia, Japan, and internationally. The company offers antifungal, immunosuppressant, oncology, cardiovascular, peptide drug, immunomodulating agents, statin, muscle relaxant, ACE inhibitor with complete DMF or COS, and other API products. It also provides specialty API immunosuppressants, including mycophenolate mofetil, rapamycin, and tacrolimus; derivative of rapamycin, such as everolimus, temsirolimus, zotarolimus, and biolimus; and echinocandin comprising caspofungin, micafungin, and anidulafungin. In addition, the company is also involved in contract manufacturing and research services. It exports its products. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. and changed its name to Chunghwa Chemical Synthesis & Biotech Co., Ltd. in January 2003. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Chunghwa Chemical Synthesis & Biotech Co Ltd data using free add-ons & libraries
Get Chunghwa Chemical Synthesis & Biotech Co Ltd Fundamental Data
Chunghwa Chemical Synthesis & Biotech Co Ltd Fundamental data includes:
- Net Revenue: 1 171 M
- EBITDA: 96 543 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Chunghwa Chemical Synthesis & Biotech Co Ltd Earnings data
What’s included:
- Latest Release: 2025-11-14
- EPS/Forecast: -0.22
Get Chunghwa Chemical Synthesis & Biotech Co Ltd End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
